Oral Thin Films Market Report 2026

Oral Thin Films Market Overview

• Oral Thin Films market size has reached to $4.99 billion in 2025 • Expected to grow to $9.82 billion in 2030 at a compound annual growth rate (CAGR) of 14.4% • Growth Driver: Rising Demand For Thin Film Drug Delivery Systems Fueling Growth In The Oral Thin Film Market • Market Trend: Increasing Focus On Product Innovations To Provide Reliable Services To Their Customers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oral Thin Films Market?

An oral thin film (OTF) is a very thin polymeric film that is applied in the mouth. The purpose of oral thin film (OTF) is to deliver therapeutic substances into the oral cavity or the stomach tract, where they are absorbed and transported directly to the circulatory system. The main types of oral thin films include sublingual film and fast dissolving dental/buccal film. The sublingual film refers to oral thin films that rapidly dissolve under the tongue and are quickly absorbed by blood with the help of tissue. It is used to treat patients who are recovering from opioid misuse disorder. These oral thin films are used in the treatment of schizophrenia, migraine, opioid dependence, nausea, and vomiting. They are sold through hospital pharmacies, retail pharmacies, and other distribution channels.

What Is The Oral Thin Films Market Growth Forecast?

The oral thin films market size is expected to see rapid growth in the next few years. It will grow to $9.82 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine delivery, rising investments in novel polymer formulations, expansion of otc oral therapeutics, growing focus on pediatric and geriatric care, increasing demand for rapid onset therapies. Major trends in the forecast period include increasing adoption of rapid-acting drug delivery films, rising demand for patient-friendly dosage forms, growing use of polymer-based film technologies, expansion of otc oral film products, enhanced focus on improved bioavailability.

Global Oral Thin Films Market Segmentation

1) By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film 2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indications 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels Subsegments: 1) By Sublingual Film: Drug Delivery Films, Nutritional Supplement Films 2) By Fast Dissolving Dental Or Buccal Film: Over-the-Counter (OTC) Products, Prescription Products

What Is The Driver Of The Oral Thin Films Market?

Rising demand for thin film drug delivery systems is propelling the growth of the oral thin film market. Thin films have been identified as a potential alternative to standard dosage forms. It is a convenient, self-administrable, and fast-dissolving dosage form for the delivery of medications, which makes it a versatile drug delivery platform. Thin films are taken orally and do not require water to be swallowed to absorb a drug. OTF is more patient-friendly due to its rapid dissolution rate. Due to these reasons, the demand for thin-film drug delivery systems is increasing, which is bringing more demand for oral thin films as well. In the United States, cardiovascular disease affects over half of all individuals. For instance, in January 2023, a report from The American Cancer Society, a US-based non-profit organization, At least 42% of newly diagnosed cancers in the US, excluding non-melanoma skin cancer, account for approximately 820,000 cases in 2023 and 840,000 cases in 2024, highlighting the growing need for advanced drug delivery methods to ensure effective treatment. Thus, increasing demand for thin film drug delivery systems is driving the growth of the oral thin film industry.

Key Players In The Global Oral Thin Films Market

Major companies operating in the oral thin films market are ZIM Laboratories Limited, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Aquestive Therapeutics Inc., BioDelivery Sciences International Inc., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, APR Applied Pharma Research SA, NAL Pharma, Panacea Biotec Ltd., Shilpa Therapeutics Pvt. Ltd., LIVKON Pharmaceuticals Pvt. Ltd., Kyu Kyu Pharmaceutical Co. Ltd., Seoul Pharma Co. Ltd., Adare Pharmaceuticals Inc., Sumitomo Dainippon Pharma Co. Ltd., Sunovion Pharmaceuticals Inc., MonoSol Rx LLC, C.L. Pharm Co. Ltd.

Global Oral Thin Films Market Trends and Insights

Major companies operating in the oral thin films market are focusing on innovative products such as Rizaport to drive revenues in their market. Rizaport is a brand-name oral thin-film formulation that contains rizatriptan benzoate, an agonist of the 5-HT1 receptor and the active ingredient of Merck & Co.'s Maxalt. For instance, in February 2024, CD Formulation, a US-based drug formulation company, launched the oral thin film technology. This offers user-friendly administration, particularly for patients with swallowing difficulties, and ensures rapid absorption by dissolving in the oral cavity, bypassing the digestive system for faster onset of action. This novel drug delivery system enhances bioavailability, allows precise dosing for individualized treatment, and improves convenience and medication adherence, especially in emergency situations.

What Are Latest Mergers And Acquisitions In The Oral Thin Films Market?

In April 2023, DifGen Pharmaceuticals LLC, a US-based healthcare technology company, acquired Aveva Drug Delivery Services Inc. for an undisclosed amount. With this acquisition, DifGen aimed to expand its R&D and manufacturing capabilities in complex drug delivery dosage forms, secure a U.S.-based manufacturing base, and increase supply resilience while offering affordable, high-quality lifesaving medications. Aveva Drug Delivery Services Inc. is a US-based manufacturing company that specializes in developing and manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Regional Outlook

North America was the largest region in the oral thin film market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Oral Thin Films Market?

The oral thin films market consists of sales of orally disintegrating and orally dissolving films. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.